2 min read

Moderna: Early Session Selloff

The reason for today's weakness is this morning's announcement by Merck (MRK) that it's developed an antiviral pill that treats Covid-19 infections, and reportedly cuts the risk of death by half, along with reduced hospitalizations.
Moderna: Early Session Selloff

This post is for paying subscribers only